deferoxamine has been researched along with Phagocyte Bactericidal Dysfunction in 1 studies
Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.
Phagocyte Bactericidal Dysfunction: Disorders in which phagocytic cells cannot kill ingested bacteria; characterized by frequent recurring infection with formulation of granulomas.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cantinieaux, B | 1 |
Hariga, C | 1 |
Ferster, A | 1 |
Toppet, M | 1 |
Fondu, P | 1 |
1 other study available for deferoxamine and Phagocyte Bactericidal Dysfunction
Article | Year |
---|---|
Desferrioxamine improves neutrophil phagocytosis in thalassemia major.
Topics: Adolescent; Adult; Child; Child, Preschool; Deferoxamine; Female; Humans; Male; Neutrophils; Phagocy | 1990 |